Scinovex
review Open AccessTop 1% cited

Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety

Frontiers in Pharmacology · 2020 · Vol. 11 · pp. 422–422
Abdullah ShaitoDuong Thi Bich ThuanHoa Thi PhuThi Hieu Dung NguyenHiba HasanSarah HalabiSamar AbdelhadyGheyath K. NasrallahAli H. EidGianfranco Pintus

Abstract

Cardiovascular diseases (CVDs) are a significant health burden with an ever-increasing prevalence. They remain the leading causes of morbidity and mortality worldwide. The use of medicinal herbs continues to be an alternative treatment approach for several diseases including CVDs. Currently, there is an unprecedented drive for the use of herbal preparations in modern medicinal systems. This drive is powered by several aspects, prime among which are their cost-effective therapeutic promise compared to standard modern therapies and the general belief that they are safe. Nonetheless, the claimed safety of herbal preparations yet remains to be properly tested. Consequently, public awareness should be raised regarding medicinal herbs safety, toxicity, potentially life-threatening adverse effects, and possible herb-drug interactions. Over the years, laboratory data have shown that medicinal herbs may have therapeutic value in CVDs as they can interfere with several CVD risk factors. Accordingly, there have been many attempts to move studies on medicinal herbs from the bench to the bedside, in order to effectively employ herbs in CVD treatments. In this review, we introduce CVDs and their risk factors. Then we overview the use of herbs for disease treatment in general and CVDs in particular. Further, data on the ethnopharmacological therapeutic potentials and medicinal properties against CVDs of four widely used plants, namely <i>Ginseng</i>, <i>Ginkgo biloba</i>, <i>Ganoderma lucidum</i>, and <i>Gynostemma pentaphyllum</i>, are gathered and reviewed. In particular, the employment of these four plants in the context of CVDs, such as myocardial infarction, hypertension, peripheral vascular diseases, coronary heart disease, cardiomyopathies, and dyslipidemias has been reviewed, analyzed, and critically discussed. We also endeavor to document the recent studies aimed to dissect the cellular and molecular cardio-protective mechanisms of the four plants, using recently reported <i>in vitro</i> and <i>in vivo</i> studies. Finally, we reviewed and reported the results of the recent clinical trials that have been conducted using these four medicinal herbs with special emphasis on their efficacy, safety, and toxicity.

Ginseng Biological Effects and ApplicationsGinkgo biloba and Cashew ApplicationsTraditional Chinese Medicine AnalysisMedicineGinsengContext (archaeology)Traditional medicineIntensive care medicineDiseaseAdverse effectMedicinal plantsAlternative medicinePharmacology

Funding

  • Qatar University
Citations
407
FWCI
18.02
field-weighted impact
References
358
Percentile
100%
vs. same field & year
Citations per year
Cited by
Plant secondary metabolites: Extraction, screening, analysis and their bioactivity
International Journal of Herbal Medicine · 2023 · 10 citations
References
Medicinal plants in therapy
Journal of Ethnopharmacology · 1987 · 1,372 citations
Natural products: A continuing source of novel drug leads
Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · 2,840 citations
Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.
Chemical and Pharmaceutical Bulletin · 1986 · 219 citations
Steaming of Ginseng at High Temperature Enhances Biological Activity
Journal of Natural Products · 2000 · 434 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.